It's a drug war, but with a difference and it's been kicked off by Cipla. CNBC TV18's Archana Shukla reports that country's second largest drug firm has slashed prices of three of its key cancer drugs by more than half, making cancer medication costs come down by over 50%.
first published: May 4, 2012 01:45 pm
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty continue its rangebound move this week? | Opening Bell
The Lawyer Renting in a 120-year-old building in South Mumbai | The Tenant
Nifty On Track To End Week Above 25,500 As Bank & Metal Stocks Lead Rebound| Closing Bell Live
Can Nifty Stage A Friday Fightback After Hitting 3-Week Low? Pine Labs IPO Opens | Opening Bell Live
